News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|November 15, 2023

The Role of the HER2 Receptor in Breast Cancer

Author(s)Sara M. Tolaney, MD, MPH

Sara M. Tolaney, MD, MPH, introduces the role of HER2 as a breast cancer cell growth receptor and explains HER2-positive versus HER2-negative.

Episodes in this series

EP. 1 The Role of the HER2 Receptor in Breast Cancer

EP. 1 The Role of the HER2 Receptor in Breast Cancer

EP. 2 Necessary Tests After a Diagnosis of Breast Cancer

EP. 2 Necessary Tests After a Diagnosis of Breast Cancer

EP. 3 Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

EP. 3 Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

EP. 4 Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

EP. 4 Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

EP. 5 Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer

EP. 5 Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer

EP. 6 Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

EP. 6 Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

EP. 7 Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

EP. 7 Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

EP. 8 How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

EP. 8 How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

EP. 9 Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response

EP. 9 Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response

EP. 10 Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

EP. 10 Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

EP. 11 Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

EP. 11 Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Kathie-Ann Joseph

The Power of Personalized Care in Breast Cancer Treatment

February 6th 2026

breast cancer

NCCN Names Trodelvy a Preferred First-Line Treatment for Metastatic TNBC

February 4th 2026

FDA

FDA Grants Breakthrough Designation to Zovegalisib for Breast Cancer

February 4th 2026

breast cancer

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

February 3rd 2026

Dr. Kathie-Ann Joseph

Breaking Down Surgical Advancements for Those With Breast Cancer

ByDr. Kathie-Ann Joseph

February 2nd 2026

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

KTX-1001 Elicits Responses in Some With Multiple Myeloma

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma

New Combination Treatment Approach Studied in Pancreatic Cancer